Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
This paper introduces eXplainable PRS (XPRS), a visualization tool that uses Shapley Additive Explanations (SHAP) to decompose polygenic risk scores (PRSs) for type 2 diabetes (T2DM) into gene-level and SNP-level contributions. The tool aims to improve the interpretability of PRSs, which are increasingly used to assess genetic predisposition to complex diseases. By employing a co-design approach incorporating legal, medical, ethical, and technical considerations via Z-inspection and HUDERIA, the study provides a framework for developing trustworthy AI systems in clinical contexts.
Unlocking the "black box" of genetic risk scores for type 2 diabetes reveals specific gene and SNP contributions, paving the way for more personalized and trustworthy AI-driven healthcare.
The polygenic risk scores (PRS) have emerged as an important methodology for quantifying genetic predisposition to complex traits and clinical disease. Significant progress has been made in applying PRS to conditions such as obesity, cancer, and type 2 diabetes (T2DM). Studies have demonstrated that PRS can effectively identify individuals at high risk, thereby enabling early screening, personalized treatment, and targeted interventions for diseases with a genetic predisposition. One current limitation of PRS, however, is the lack of interpretability tools. To address this problem for T2DM, researchers at the Graduate School of Data Science at the Seoul National University introduced eXplainable PRS (XPRS). This visualization tool decomposes PRSs into gene-level and single-nucleotide polymorphism (SNP) contribution scores via Shapley Additive Explanations (SHAP), providing granular insights into the specific genetic factors driving an individual's risk profile. We used a co-design approach to assess XPRS trustworthiness by considering legal, medical, ethical, and technical robustness during early design and potential clinical use. For that, we used Z-inspection, an ethically aligned Trustworthy AI co-design methodology, and piloted the Council of Europe's Human Rights, Democracy, and the Rule of Law Impact Assessment for AI Systems (HUDERIA) (Council of Europe (CAI) 2025). The findings of this use-case comprise a comprehensive set of ethical, legal, and technical lessons learned. These insights, identified by a multidisciplinary team of experts (ethics, legal, human rights, computer science, and medical), serve as a framework for designers to navigate future challenges with this and other AI systems. The findings also provide a useful reference for researchers developing explainability frameworks for PRS in diverse clinical contexts.